Bandingkan Harga & Kinerja Asiaplast Industries Tbk (APLI) vs UBC Medical Indonesia Tbk. (LABS)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Asiaplast Industries Tbk dan UBC Medical Indonesia Tbk.: Asiaplast Industries Tbk diperdagangkan di Rp254 (kapitalisasi pasar 351,57 M, volume 24 jam 27,4 rb), sedangkan UBC Medical Indonesia Tbk. diperdagangkan di Rp161 (kapitalisasi pasar 635,95 M, volume 24 jam 288,1 rb). Perbedaan utamanya: UBC Medical Indonesia Tbk. lebih besar dari sisi kapitalisasi pasar, dan UBC Medical Indonesia Tbk. lebih aktif diperdagangkan (288,1 rb vs 27,4 rb). Mana yang lebih baik tergantung tujuan investasimu.
| APLI | LABS | |
|---|---|---|
Kapitalisasi Pasar | 351,57 M | 635,95 M |
Volume | 27,4 rb | 288,1 rb |
Lot | 274 | 2,88 rb |
Perputaran | 6,96 jt | 46,81 jt |
Harga Rata-rata | 253,88 | 162,49 |
Nilai Transaksi | 6,96 jt | 46,81 jt |
Harga Ekuilibrium Indikatif | 256 | 163 |
Volume Ekuilibrium Indikatif | 1 | 16 |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Asiaplast Industries Tbk
PT. Asiaplast Industries Tbk, formerly PT. Akasa Pandukarya and originally known as PT. Adi Karya Perkasa. The company started its commercial operations in 1994. Since November 1999, the company started to produce PVC synthetic leather. As of December 31, 2000, the Company has five production lines comprising of production lines I, II and III, which are used for producing PVC plastic sheets, with production capacity of 15,000 tons per year (un audited) and production lines IV, V, which are used for producing synthetic leather, with production capacity of 6, 500 tons per year (un audited). The Capital Investment Coordinating Board has approved the change of the Companys status from foreign capital investment to become domestic capital investment based on the letter No. 24/1/IP/I/PMDN/2015 dated February 18, 2015.
Selengkapnya di halaman APLI →Tentang UBC Medical Indonesia Tbk.
PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Selengkapnya di halaman LABS →
